Stay updated on IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedA new revision (v3.3.4) was added to the study record history, and the previous revision (v3.3.3) was removed, indicating a bookkeeping update to the page.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedA new Revision: v3.3.3 was added to the study record history, and the HHS Vulnerability Disclosure link along with the Revision: v3.3.2 entry were removed from the page.SummaryDifference0.2%

- Check44 days agoChange DetectedThe revision history shows a minor update with an addition of Revision: v3.3.2 and deletion of Revision: v3.3.1. These changes are system maintenance details and do not affect study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedRecord History now includes a new revision version (v3.3.1) and shows removal of the previous revision (v3.2.0) in the study's history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedRemoved the generic operating-status notice regarding funding and update timing. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check73 days agoChange DetectedThe record history shows multiple versions with updates to recruitment status and study status, reflecting ongoing changes to the trial's current state over time.SummaryDifference0.1%

Stay in the know with updates to IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.